Literature DB >> 7132858

Encephalopathy from bismuth subsalicylate.

G J Hasking, J M Duggan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7132858     DOI： 10.5694/j.1326-5377.1982.tb124313.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  7 in total

Review 1.  An understanding of excessive intestinal gas.

Authors:  F L Suarez; M D Levitt
Journal:  Curr Gastroenterol Rep       Date:  2000-10

2.  Site of bismuth absorption from bismuth subsalicylate: implications for treatment of colonic conditions.

Authors:  F L Suarez; J Furne; J Stiehm; C Garten; M D Levitt
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

3.  Prevention of traveler's diarrhea by the tablet form of bismuth subsalicylate.

Authors:  R Steffen; H L DuPont; R Heusser; A Helminger; F Witassek; M D Manhart; M Schär
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

4.  Disposition of bismuth in the rat. I. Red blood cell and plasma protein binding.

Authors:  N Rao; S Feldman
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

Review 5.  Adverse effects of drugs used in the management of constipation and diarrhoea.

Authors:  J M Gattuso; M A Kamm
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

Review 6.  Pharmacokinetics and toxicity of bismuth compounds.

Authors:  A Slikkerveer; F A de Wolff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct

7.  Oral bismuth for chronic intractable diarrheal conditions?

Authors:  Sony S Thazhath; Mazhar Haque; Timothy H Florin
Journal:  Clin Exp Gastroenterol       Date:  2013-03-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.